• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清胃蛋白酶原I和II水平在胃癌大规模筛查中的临床应用

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

作者信息

Miki K, Ichinose M, Ishikawa K B, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y

机构信息

First Department of Internal Medicine, Faculty of Medicine, University of Tokyo.

出版信息

Jpn J Cancer Res. 1993 Oct;84(10):1086-90. doi: 10.1111/j.1349-7006.1993.tb02805.x.

DOI:10.1111/j.1349-7006.1993.tb02805.x
PMID:8226283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5919064/
Abstract

A considerable number of gastric cancers derive from stomach mucosa where chronic atrophic gastritis is severe and extensive. Based on the fact that the serum pepsinogen levels provide a precise measure of the extent of chronic atrophic gastritis, we have devised a mass screening method involving serum pepsinogen measurement to identify subjects at high risk of gastric cancer. In 1991, we screened 4,647 workers (male: 4,113, female: 534, mean age: 49.0 years) at a Japanese company using this method. Out of 875 subjects (18.8%) with a serum pepsinogen I level of less than 50 micrograms/liter and a pepsinogen I/II ratio of less than 3.0, 676 subjects (14.5%) were selected for further investigation by endoscopy. This led to the detection of four subjects (0.086%) with gastric cancer (three in an early stage) and four subjects with adenoma. The cancer detection rate of this new screening method was comparable, and in some respects superior, to that of the traditional barium X-ray screening. Since the incidence of test-positive subjects was as low as 10% amongst subjects aged less than 40, this screening method appears to be especially useful for screening of younger generations. The new method is less expensive than the traditional barium X-ray and subjects experience little discomfort. Further, many serum samples can be quickly measured simultaneously. The results of this study have indicated that serum pepsinogen screening provides a valuable method for detecting gastric cancers.

摘要

相当一部分胃癌起源于慢性萎缩性胃炎严重且广泛的胃黏膜。基于血清胃蛋白酶原水平能精确衡量慢性萎缩性胃炎程度这一事实,我们设计了一种通过检测血清胃蛋白酶原进行大规模筛查的方法,以识别胃癌高危人群。1991年,我们用此方法对一家日本公司的4647名员工(男性4113名,女性534名,平均年龄49.0岁)进行了筛查。在血清胃蛋白酶原I水平低于50微克/升且胃蛋白酶原I/II比值低于3.0的875名受试者(18.8%)中,有676名受试者(14.5%)被选出来接受进一步的内镜检查。结果发现了4名胃癌患者(0.086%,其中3名处于早期)和4名腺瘤患者。这种新筛查方法的癌症检出率与传统的钡餐X线筛查相当,在某些方面甚至更优。由于在40岁以下的受试者中,检测呈阳性的比例低至10%,所以这种筛查方法似乎对年轻一代的筛查特别有用。新方法比传统钡餐X线检查成本更低,受试者不适感小。此外,许多血清样本可以同时快速检测。本研究结果表明,血清胃蛋白酶原筛查为胃癌检测提供了一种有价值的方法。

相似文献

1
Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.血清胃蛋白酶原I和II水平在胃癌大规模筛查中的临床应用
Jpn J Cancer Res. 1993 Oct;84(10):1086-90. doi: 10.1111/j.1349-7006.1993.tb02805.x.
2
The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.与荧光摄影相比,利用血清胃蛋白酶原水平进行胃癌群体筛查的实用性。
Hiroshima J Med Sci. 1997 Jun;46(2):81-6.
3
[Pepsinogen].[胃蛋白酶原]
Nihon Rinsho. 1995 May;53(5):1198-202.
4
Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.日本人群血清胃蛋白酶原I与II的比值与胃癌及腺瘤患病率的相关性
Am J Gastroenterol. 1998 Jul;93(7):1090-6. doi: 10.1111/j.1572-0241.1998.00335.x.
5
Serum pepsinogen and gastric cancer screening.血清胃蛋白酶原与胃癌筛查。
Intern Med. 2007;46(6):261-6. doi: 10.2169/internalmedicine.46.6181. Epub 2007 Mar 15.
6
The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.低血清胃蛋白酶原水平对检测日本人群中与广泛慢性胃炎相关的胃癌的意义。
Jpn J Cancer Res. 1989 Feb;80(2):111-4. doi: 10.1111/j.1349-7006.1989.tb02276.x.
7
Usefulness of gastric cancer screening using the serum pepsinogen test method.采用血清胃蛋白酶原检测法进行胃癌筛查的效用
Am J Gastroenterol. 2003 Apr;98(4):735-9. doi: 10.1111/j.1572-0241.2003.07410.x.
8
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.通过血清胃蛋白酶原、胃泌素-17和幽门螺杆菌免疫球蛋白G抗体筛查萎缩性胃炎和胃癌。
J Dig Dis. 2007 Feb;8(1):15-22. doi: 10.1111/j.1443-9573.2007.00271.x.
9
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.通过血清胃蛋白酶原检测确定的癌症高危人群:无症状中年男性10年随访结果
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):838-45. doi: 10.1158/1055-9965.EPI-07-2762.
10
Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.血清胃蛋白酶原作为青年胃癌的一种新标志物。青年胃癌预防研究组。
Cancer. 1994 Jun 1;73(11):2695-702. doi: 10.1002/1097-0142(19940601)73:11<2695::aid-cncr2820731108>3.0.co;2-o.

引用本文的文献

1
Association of serum pepsinogens and gastrin-17 with infection assessed by urea breath test.血清胃蛋白酶原和胃泌素-17与尿素呼气试验评估的感染的关系。
Front Cell Infect Microbiol. 2022 Aug 16;12:980399. doi: 10.3389/fcimb.2022.980399. eCollection 2022.
2
Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.人类胃癌风险筛查:从大鼠胃蛋白酶原研究到 ABC 法。
Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(8):462-478. doi: 10.2183/pjab.97.023.
3
Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Infection in a Low-Prevalence Country: A Report from Sri Lanka.胃蛋白酶原和血清IgG检测是低流行率国家感染的一种有价值的诊断方法:来自斯里兰卡的报告。
Diagnostics (Basel). 2021 Jul 29;11(8):1364. doi: 10.3390/diagnostics11081364.
4
Factors for Negative Result in Serum Anti-Helicobacter pylori IgG Antibody Test in Adult Subjects With Nodular Gastritis: A Single-center Study.结节性胃炎成年患者血清抗幽门螺杆菌IgG抗体检测结果为阴性的相关因素:一项单中心研究
Cureus. 2021 Jun 14;13(6):e15651. doi: 10.7759/cureus.15651. eCollection 2021 Jun.
5
Screening for gastric cancer in China: Advances, challenges and visions.中国胃癌筛查:进展、挑战与展望
Chin J Cancer Res. 2021 Apr 30;33(2):168-180. doi: 10.21147/j.issn.1000-9604.2021.02.05.
6
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.血浆硫氧还蛋白还原酶活性作为胃癌的一种新型生物标志物。
Sci Rep. 2019 Dec 13;9(1):19084. doi: 10.1038/s41598-019-55641-6.
7
Eradication therapy for infection improves nutrition status in Japanese hemodialysis patients: a pilot study.根除感染治疗可改善日本血液透析患者的营养状况:一项试点研究。
J Clin Biochem Nutr. 2019 Jan;64(1):91-95. doi: 10.3164/jcbn.18-61. Epub 2018 Oct 2.
8
Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection.血清胃蛋白酶原值与日本初中生幽门螺杆菌感染的关系。
J Epidemiol. 2020 Jan 5;30(1):30-36. doi: 10.2188/jea.JE20180119. Epub 2019 Jan 12.
9
Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection.血清胃蛋白酶原值用于幽门螺杆菌感染的最佳标准和诊断能力。
J Epidemiol. 2019 Apr 5;29(4):147-154. doi: 10.2188/jea.JE20170094. Epub 2018 Sep 22.
10
Pepsinogen C expression, regulation and its relationship with cancer.胃蛋白酶原C的表达、调控及其与癌症的关系。
Cancer Cell Int. 2017 May 23;17:57. doi: 10.1186/s12935-017-0426-6. eCollection 2017.

本文引用的文献

1
The serum pepsinogen level with special reference to the histology of the gastric mucosa.血清胃蛋白酶原水平与胃黏膜组织学的特别关联
Gut. 1963 Jun;4(2):106-11. doi: 10.1136/gut.4.2.106.
2
Blood plasma pepsinogen. II. The activity of the plasma from normal subjects, patients with duodenal ulcer, and patients with pernicious anemia.血浆胃蛋白酶原。II. 正常受试者、十二指肠溃疡患者及恶性贫血患者血浆的活性。
J Lab Clin Med. 1952 Aug;40(2):188-99.
3
Atrophic gastritis as a possible precursor of gastric carcinoma and pernicious anemia. Results of follow-up examinations.萎缩性胃炎作为胃癌和恶性贫血的一种可能前驱病变。随访检查结果。
Acta Med Scand. 1960 May 5;166:455-74. doi: 10.1111/j.0954-6820.1960.tb17401.x.
4
Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations.匈牙利和意大利无症状人群中的萎缩性胃炎及肠化生
Endoscopy. 1980 May;12(3):105-8. doi: 10.1055/s-2007-1021722.
5
Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.正常对照者和患有各种疾病的患者血清I型和II型胃蛋白酶原的放射免疫测定
Clin Chim Acta. 1982 Dec 9;126(2):183-91. doi: 10.1016/0009-8981(82)90034-1.
6
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.血清胃蛋白酶原I、血清胃蛋白酶原II与胃黏膜组织学之间的关系。一项针对恶性贫血患者亲属的研究。
Gastroenterology. 1982 Jul;83(1 Pt 2):204-9.
7
Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma.关于胃癌高发病率的日本慢性胃炎
J Natl Cancer Inst. 1971 Jul;47(1):179-95.
8
Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach.通过对胃小弯和大弯进行逐步活检确定胃底-幽门边界的时间顺序转变。
Gastroenterology. 1972 Oct;63(4):584-92.
9
A clinical and statistical follow-up study of atrophic gastritis.萎缩性胃炎的临床与统计学随访研究
Am J Dig Dis. 1973 Dec;18(12):1061-5. doi: 10.1007/BF01076522.
10
Serum pepsinogens as a screening test of extensive chronic gastritis.血清胃蛋白酶原作为广泛型慢性胃炎的筛查试验。
Gastroenterol Jpn. 1987 Apr;22(2):133-41. doi: 10.1007/BF02774209.